Freshpet (NASDAQ:FRPT) 주식

FRESHPET INC

Freshpet

Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.

Photo: Courtesy of Bill Jerome on Flickr

Trading Ideas

BARK

CHWY

FRPT

LMND

PETS

TRUP

WOOF

투자자 라이언 코헨(Ryan Cohen)은 애완동물 용품 및 애완동물 건강 제품의 성장 추세에 맞춰 2011년에 츄이(NYSE:CHWY)를 설립했다. 새로운 데이터에 따르면 코헨은 애완동물 용품 및 애완동물 보험에 대한 지출이 크게 증가하는 등 이러한 추세에 초기에 대처했을 수 있었다. 일부는 벌써 그를 전설적인 투자자(GOAT, greatest of all time)들 중 한 명으로 보고 있다. 

라이언 코헨은 GOAT? 츄이의 창립은 애완동물 용품 분야에서 엄청난 추세를 미리 예상

Freshpet Inc

<a href="https://www.sec.gov/Archives/edgar/data/1998597/000090266425002348/xslForm13F_X02/infotable.xml" title="https://www.sec.gov/Archives/edgar/data/1998597/000090266425002348/xslForm13F_X02/infotable.xml">https://www.sec.gov/Archives/edgar/data/1998597/000090266425002348/xslForm13F_X02/infotable.xml</a>

News

TRMB

WOLF

JANA Partners 13F Filing Shows Increased Stake In Lamb Weston By 854,087 Shares; Increased Stake In Markel Group By 47,096 Shares; Increased Stake In Rapid7 By 415,927 Shares; Decreased Stake In Trimble By 232,861 Shares; Sold Complete Stake In Wolfspeed; New Position Of Freshpet With 734,763 Shares

Cineplex operator Cinemark Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) presently operates under the framework of two sets of facts. Both facts can be true at the same time. Still, at a certain point, one narrative will likely become truer than the other, making <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45209210/box-office-momentum-pushes-cinemark-past-forecasts-says-analyst">CNK stock</a> one of the most fascinating (albeit risky) ideas.
On one hand, Cinemark is a beneficiary of intense speculative fervor. Ordinarily, investors may not be so quick to overlook — let alone reward — a <a href="https://www.benzinga.com/news/earnings/25/05/45169195/whats-going-on-with-cinemark-stock-today">mixed earnings performance</a>. Yet late last week, market participants ignored convention when the company disclosed a quarterly per-share loss of 32 cents in the first quarter, well off the consensus view of a 10-cent loss.
True, sales in the period of $540.7 million managed to just beat out analysts' target of $540.68 million. Nevertheless, the tally represented a 6.6% decline on a year-over-year basis. It should be noted that the slate of movies during this time were weak. Also, management stated that the business still suffered lingering effects of the 2023 Hollywood strikes. Even so, the circumstances aren't exactly encouraging for Cinemark.
For retail investors, the challenges apparently didn't matter, with CNK stock responding strongly despite the mixed numbers. After a brief selloff on Monday, shares have stormed higher, fueled potentially by <a href="https://www.benzinga.com/money/what-is-a-short-squeeze">short-squeeze speculation</a>.
At the moment, CNK's short interest stands at a <a href="https://www.benzinga.com/quote/CNK/short-interest">staggering 33.3% of its float</a>, while its short interest ratio is 4.99 days to cover. Therefore, it would take approximately a week (based on average trading volume) for the bears to fully unwind their short exposure.
As pet food company Freshpet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) has demonstrated, <a href="https://www.benzinga.com/news/earnings/25/05/45236387/frpt-stock-short-squeeze-mixed-q1-earnings">short squeezes can extract robust performances</a> for an extended period. Therefore, CNK stock can stay elevated for quite some time.
<h2 class="wp-block-heading">Sustainability Challenges May Eventually Weigh On CNK Stock</h2>
Adding to the remarkable rally is that this isn't Cinemark's first rodeo in terms of extended bullishness. Assuming that CNK stock can finish out this week in the black, it will have generated six straight weeks of upside. Such a streak has occurred three times over the past 10 years — and has only reversed one time.
Frankly, it's difficult to read too much into a sample size of three datapoints. Nevertheless, the available empirical data suggests that short-squeeze pressure on CNK stock can last for a while.
On the other hand, no asset continues to rise indefinitely without encountering some challenges, which raises the other set of facts: CNK stock has difficulty sustaining bullish dominance.
As circumstances stand now, CNK is printing an "8-2" sequence: eight weeks of upside (six of them consecutive) mixed with two weeks of downside. The issue, though, is that this bullish-dominant sequence has only materialized 10 times in the past decade — and seven of the cases resulted in a downcycle for the following week.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07153828/CNK-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-906571" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07153828/CNK-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07153828/CNK-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07153828/CNK-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07153828/CNK-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
What's more, the 7-3 sequence — which has occurred 48 times — features a downside probability in the following week of 60.42%. Stated differently, as the euphoria fades, there's a greater risk that the weaker hands among the optimists get skittish about the elevated valuation.
Fundamentally, and this relates to the other truth about CNK's sustainability issue, the cineplex industry is fighting to beat expectations in a shrinking market. Going back to Cinemark's first-quarter earnings report, admissions revenue dipped 8.9% to $264.1 million, stemming from an attendance figure that declined 7.8% to 36.6 million patrons.
Granted, Cinemark performed admirably in light of the context — that cannot be ignored. But the shrinking arena also cannot be casually dismissed.
<h2 class="wp-block-heading">A High-Stakes Bearish Gamble</h2>
With the freight train still rolling for CNK stock, it's wise not to fight the tape. At some point, though, the fervor may eventually fade, with reality then taking the wheel. At that point, it's possible the bears could take control of the market.
For emotionally agnostic traders, then, the 31/29 bear put spread expiring June 20 appears tempting. This transaction involves buying the $31 put and simultaneously selling the $29 put, for a net debit paid of $80. Should CNK stock fall through the short strike price of $29 at expiration, the maximum reward at time of writing is $120, or a 150% payout.
Granted, CNK stock is extremely difficult to decipher because of the extremely high short interest, which usually doesn't neatly resolve linearly. However, based on prior trends — combined with some speculation to account for the short interest — CNK has an arguably solid chance of falling to the short strike price over the next several weeks.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45209210/box-office-momentum-pushes-cinemark-past-forecasts-says-analyst">Box Office Momentum Pushes Cinemark Past Forecasts, Says Analyst</a></li>
</ul>
Photo: Shutterstock

Equities

Options

Options Corner: Cinemark's Short Squeeze Won't Prevent The Credits From Eventually Rolling

On paper, pet food products specialist Freshpet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) should be struggling for traction — and on a wider scale, it certainly is. Since the beginning of the year, FRPT stock is down about 45%, a staggering loss. Further, mixed results from the company's <a href="https://www.benzinga.com/25/05/45193586/why-pet-food-company-freshpets-stock-is-sliding-today">first-quarter earnings report</a> didn't help improve the picture. Nevertheless, the market has other ideas, making the equity an intriguing idea for risk-tolerant speculators.
At the start of this week before the opening bell, Freshpet disclosed first-quarter revenue that increased 17.6% on a year-over-year basis to $263.25 million, outpacing analysts' consensus view of $260.12 million. Volume gains of 14.9%, along with a favorable price/mix of 2.7%, contributed to the lift in net sales.
However, the financial performance went off course in terms of the bottom line. Specifically, the adjusted loss per share landed at 26 cents, missing the consensus target of earnings per share of 10 cents.
Moreover, despite management's positive framing, it was difficult to ignore the obvious concerns facing Freshpet's core business. Admitting the obstacles inherent in the current economic paradigm, the leadership team lowered its fiscal year 2025 sales outlook from a range of $1.18 billion to $1.21 billion, down to $1.12 billion to $1.15 billion. On the other end, analysts were anticipating an outlook revision to $1.18 billion.
Still, even with these overall disappointing figures, FRPT stock has been on the rise. Helping to fuel upward speculation is the security's <a href="https://www.benzinga.com/quote/FRPT/short-interest">elevated short interest</a>. Presently, FRPT's short interest as a percentage of float clocks in at 15.3%. What's more, the short interest ratio stands at 4.99 days to cover, meaning that it would take one week (based on average trading volume) for the bears to unwind their position.
In other words, this <a href="https://www.benzinga.com/money/what-is-a-short-squeeze">short squeeze</a> — or the "reverse" panic stemming from being on the opposite side of market momentum — could last for some time.
<h2 class="wp-block-heading">Trading FRPT Stock While The Deck Is Hot</h2>
Although it doesn't look like it given the security's penchant for devastating volatility, FRPT stock historically demonstrates an upward bias. Using data since January 2019, the chances that a long position will be profitable over a one-week span is 54.38%. In its natural state, investors can generally expect decent performance out of this solid middle-capitalization entity.
However, from a trading perspective, 54% isn't that much of a probabilistic edge. Indeed, with such a small advantage, going for big payout strategies may represent a speculation trap. Instead, it may be better to wait for the target security to enter a more advantageous phase — essentially when the deck becomes hot in favor of the bettor rather than the house.
Statistically, it's improbable for a publicly traded security's baseline odds to stay static across sentiment regimes. During periods of extreme fear or greed, the odds of long-side success may shift dramatically from the baseline, presenting superior setups for speculators.
Regarding Freshpet, in the last 10 weeks, its stock printed a "3-7" sequence: three weeks of upside combined with seven weeks of downside, with an overall net negative trajectory across the period. The significance of this pattern is that it appears to be a reversal signal. First, there have only been two cases of 2-8 sequences in the past 10 years.
Second and more importantly, there's a 62.79% chance of upside in the subsequent week following the flashing of the 3-7 sequence. What's more, the median one-week return under the positive pathway stands at 5.1%, whereas the median loss under the negative pathway is 3.14%. Thus, the risk-reward profile from a payout perspective is also asymmetrically favorable to the bullish speculator.
<h2 class="wp-block-heading">Plotting An Aggressive Multi-Leg Strategy For Freshpet</h2>
Over the next 10 weeks, if the positive pathway wins out, FRPT stock could see an early swing higher before the momentum tapers off, resulting in a price target around $81. Should the negative pathway win out, investors may see some choppiness before a stabilization point around $77.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06145047/FRPT-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-904206" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06145047/FRPT-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06145047/FRPT-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06145047/FRPT-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06145047/FRPT-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
It all comes down to the short squeeze, which is notoriously difficult to predict.
Aggressive traders may consider the 82.50/85 bull call spread expiring May 16, which is probably the highest one can reach for while still being rational. This transaction involves buying the 82.50 call and simultaneously selling the $85 call, for a net debit paid (at time of writing) of $130. Should FRPT stock rise through the short strike price of $85 at expiration, the maximum reward is $120, a payout of over 92%.
If all goes to plan, the above trade should take advantage of any remaining momentum from the potential short squeeze. However, if circumstances go awry, the bull spread's capped-risk profile would keep the most that can be lost at the net debit paid of $130.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45205461/mcd-stock-contrarian-buy-despite-q1-earnings-disappointment">Options Corner: McDonald&#8217;s Signals A &#8216;Hot Deck&#8217; For Aggressive Speculators</a></li>
</ul>
Photo: Shutterstock

Earnings

Long Ideas

Options Corner: Short-Squeeze Pressure Continues To Fuel Freshpet's Contrarian Rally

JP Morgan analyst Ken Goldman maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Neutral and lowers the price target from $91 to $85.

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on Freshpet, Lowers Price Target to $85

Benchmark analyst Todd Brooks maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and lowers the price target from $140 to $120.

Benchmark Maintains Buy on Freshpet, Lowers Price Target to $120

Wells Fargo analyst Marc Torrente maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Overweight and lowers the price target from $110 to $100.

Wells Fargo Maintains Overweight on Freshpet, Lowers Price Target to $100

Baird analyst Peter Benedict maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Outperform and lowers the price target from $125 to $115.

Baird Maintains Outperform on Freshpet, Lowers Price Target to $115

Shares of pet food company Freshpet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) were <a href="https://www.benzinga.com/premarket">trading lower in premarket </a>on Monday after the first-quarter FY25 earnings.
The company reported <a href="https://www.benzinga.com/pressreleases/25/05/g45189874/freshpet-inc-reports-first-quarter-2025-financial-results" target="_blank" rel="noopener">a first-quarter revenue increase </a>of 17.6% year over year to $263.25 million, beating the analyst consensus estimate of $260.12 million.
The increase in net sales was primarily driven by volume gains of 14.9% and favorable price/mix of 2.7%.
Gross profit increased 17.6% year over year to $103.8 million, with the margin consistent at 39.4% for both periods. The benefit from lower input costs and reduced quality costs was fully offset by reduced leverage on plant expenses.
Selling, general and administrative expenses rose 44.6% to $115.3 million. The company reported an operating loss of $(11.5) million for the quarter compared to an operating income of $8.5 million last year.
Also Read: <a href="https://www.benzinga.com/general/restaurants/25/05/45177147/mcdonalds-stumbles-on-weak-traffic-despite-margin-gains-and-analyst-optimism">McDonald&#8217;s Stumbles On Weak Traffic, Despite Margin Gains And Analyst Optimism</a>
Adjusted EBITDA was $35.5 million, compared to $30.6 million last year. EPS loss of $(0.26)&nbsp;<a href="https://www.benzinga.com/earnings">missed the consensus</a> estimate of $0.10.
As of March 31, 2025, the company held $243.7 million in cash and equivalents. The operating cash flow for the quarter was $4.8 million.
&#8220;Despite the recent macro-economic headwinds, we believe Freshpet remains a structurally advantaged business with a long runway for growth in a category with long-term tailwinds,&#8221; said CEO Billy Cyr. &#8220;However, our growth year-to-date has not been as robust as we had anticipated so we are adapting our growth plans to the current economic challenges that our consumers are facing while continuing to drive the operational improvements that are essential to our long-term success.&#8221; 
Outlook: Freshpet lowered its FY25 sales outlook from $1.18 billion—$1.21 billion to $1.12 billion—$1.15 billion, compared to an estimate of $1.18 billion.
The company expects adjusted EBITDA of $190 million—$210 million, and FRPT expects capital expenditures of ~$225 million.
Price Action: FRPT shares traded lower by 2.83% at $74.20 in premarket at last check Monday.
Read Next: <a href="https://www.benzinga.com/25/05/45179419/estee-lauders-beauty-gains-cant-offset-global-headwinds-says-analyst">Estée Lauder&#8217;s Beauty Gains Can&#8217;t Offset Global Headwinds, Says Analyst</a>
Photo: Shutterstock

General

Why Is Pet Food Company Freshpet's Stock Sliding Today?

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is a 75.68 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $263.25 million which beat the analyst consensus estimate of $260.12 million by 1.20 percent. This is a 17.60 percent increase over sales of $223.85 million the same period last year.

Earnings Beats

Freshpet Q1 Adj. EPS $0.09, Inline, Sales $263.25M Beat $260.12M Estimate

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $0.10 by 360 percent. This is a 170.27 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $263.25 million which beat the analyst consensus estimate of $260.12 million by 1.20 percent. This is a 17.60 percent increase over sales of $223.85 million the same period last year.

Earnings Misses

Freshpet Q1 EPS $(0.26) Misses $0.10 Estimate, Sales $263.25M Beat $260.12M Estimate

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) lowers FY2025 sales outlook from $1.18 billion-$1.21 billion to $1.12 billion-$1.15 billion vs $1.18 billion estimate.

Guidance

Freshpet Lowers FY2025 Sales Guidance from $1.18B-$1.21B to $1.12B-$1.15B vs $1.18B Est

ACEL

ADEA

ADUS

AESI

AMRC

AOMR

AORT

ARES

AROC

AXSM

BCRX

BCSF

BFAM

BNTX

BRBR

BRCC

BWXT

CERT

CORT

CRBG

CRGY

CSTL

CTRA

DENN

DMRC

DORM

EKSO

ESCA

EVER

FANG

GBDC

GECC

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HSIC

HSII

HSTM

IART

ICHR

INSP

IPAR

IRMD

JBTM

JELD

JRVR

LSCC

MATX

MYPS

NBIX

NGVT

NMFC

NSSC

NVTS

OCUL

OPAD

OTTR

PLMR

PLOW

PLTR

PLYA

PRAA

PRIM

RAIL

RAND

Earnings Scheduled For May 5, 2025

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) will release its quarterly earnings report on Monday, 2025-05-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Freshpet to report an earnings per share (EPS) of $0.32.
Anticipation surrounds Freshpet's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings History Snapshot</h3>
The company's EPS missed by $0.05 in the last quarter, leading to a 5.74% drop in the share price on the following day.
Here's a look at Freshpet's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.11</td>
<td>-0.03</td>
<td>-0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.36</td>
<td>0.24</td>
<td>-0.03</td>
<td>0.37</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>1.0%</td>
<td>5.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746219759_0.png" alt="eps graph" />
<h3>Performance of Freshpet Shares</h3>
Shares of Freshpet were trading at $72.72 as of May 01. Over the last 52-week period, shares are down 36.91%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Insights Shared by Analysts on Freshpet</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Freshpet.
The consensus rating for Freshpet is Buy, derived from 17 analyst ratings. An average one-year price target of $126.29 implies a potential 73.67% upside.
<h3>Comparing Ratings with Competitors</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Flowers Foods, Simply Good Foods and Nomad Foods, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Flowers Foods, with an average 1-year price target of $20.5, suggesting a potential 71.81% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Simply Good Foods, with an average 1-year price target of $40.4, suggesting a potential 44.44% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Nomad Foods, with an average 1-year price target of $24.5, suggesting a potential 66.31% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
The peer analysis summary provides a snapshot of key metrics for Flowers Foods, Simply Good Foods and Nomad Foods, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Freshpet</td>
<td>Buy</td>
<td>21.95%</td>
<td>$111.60M</td>
<td>1.75%</td>
</tr>
<tr>
<td>Flowers Foods</td>
<td>Neutral</td>
<td>-1.59%</td>
<td>$542.66M</td>
<td>3.06%</td>
</tr>
<tr>
<td>Simply Good Foods</td>
<td>Neutral</td>
<td>15.20%</td>
<td>$130.14M</td>
<td>2.04%</td>
</tr>
<tr>
<td>Nomad Foods</td>
<td>Outperform</td>
<td>4.29%</td>
<td>$225.90M</td>
<td>1.92%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Freshpet ranks highest in Revenue Growth among its peers, with a growth rate of 21.95%. In terms of Gross Profit, Freshpet is at the bottom with $111.60M. For Return on Equity, Freshpet is also at the bottom with a rate of 1.75%.
<h3>Discovering Freshpet: A Closer Look</h3>
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.
<h3>Freshpet: Delving into Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Freshpet displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 21.95%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Freshpet's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 6.9% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Freshpet's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 1.75%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Freshpet's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.17%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.4, Freshpet adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/FRPT/earnings">To track all earnings releases for Freshpet visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

An Overview of Freshpet's Earnings

Truist Securities analyst Bill Chappell downgrades Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) from Buy to Hold and lowers the price target from $90 to $80.

Downgrades

Truist Securities Downgrades Freshpet to Hold, Lowers Price Target to $80

DA Davidson analyst Brian Holland upgraded Utz Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTZ#NYSE">UTZ</a>) from Neutral to Buy on Thursday, <a href="https://www.benzinga.com/quote/UTZ/analyst-ratings" target="_blank" rel="noreferrer noopener">maintaining the price forecast of $16.</a>
The analyst sees a compelling &#8220;risk-reward&#8221; setup for Utz Brands despite broader challenges in the food sector.
Holland highlights several supportive factors, including a firming position in the salty snacks category, which benefits from reduced promotional pressure and Utz Brands&#8217; strong performance in non-tracked retail channels.
Additionally, the company has exceeded expectations in transforming its supply chain, potentially setting the stage for upward earnings revisions if its recent market share gains continue.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44988897/china-trade-war-4-big-brand-stocks-that-will-suffer-most" rel="noreferrer noopener">China Trade War: 4 Big-Brand Stocks That Will Suffer Most</a>
The analyst also notes that, aside from names like Freshpet, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) and SunOpta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>), no other food stock is currently trading at &#8220;a wider relative valuation gap.&#8221;
The company released<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44861060/utz-appoints-william-j-kelley-jr-as-chief-financial-officer" rel="noreferrer noopener"> 1Q25 preliminary results released last week.</a>
Although overall sales in the salty snack category have remained weak due to inflation-driven volume pressure, growing health consciousness, and possible impacts from GLP-1 usage, the analyst notes that Utz Brands has steadily gained market share.
This modest but consistent share growth has been driven by expanded distribution, increased marketing efforts, and product innovation targeting largely untapped markets—particularly in regions that account for over 60% of salty snack sales.
While competitive promotions, especially from dominant players like Frito-Lay, created challenges through 2024, the lack of sustained volume gains from those promos led to a market reset, the analyst writes.
Price Action: Utz shares are trading higher by 1.61% to $13.60 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44989420/vinfast-auto-maintains-ev-delivery-outlook-amid-macro-uncertainty-despite-q4-margin-drag" target="_blank" rel="noreferrer noopener">VinFast Auto Maintains EV Delivery Outlook Amid Macro Uncertainty Despite Q4 Margin Drag</a></li>
</ul>
Image: Shutterstock

Markets

Movers

STKL

Utz Brands Gets Analyst Upgrade As Salty Snacks Gain Traction, Promotions Ease

Truist Securities analyst Bill Chappell maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and lowers the price target from $110 to $90.

Truist Securities Maintains Buy on Freshpet, Lowers Price Target to $90

WIIM

CART

CASY

Coca-Cola European Partners plc Ordinary Shares

CCEP

CELH

CHEF

COKE

FIZZ

HNST

LFVN

LOCL

MGRX

PFGC

SISI

SMPL

USFD

Shares of companies within the broader consumer staples sector are trading lower amid overall market weakness.

Benchmark analyst Todd Brooks maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and lowers the price target from $195 to $140.

Benchmark Maintains Buy on Freshpet, Lowers Price Target to $140

COTY

Shares of companies within the broader consumer staples sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

Stifel analyst Mark Astrachan maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and lowers the price target from $135 to $115.

Stifel Maintains Buy on Freshpet, Lowers Price Target to $115

Press Releases

Freshpet, Inc. to Participate in the Morgan Stanley Global Consumer & Retail Conference

Freshpet, Inc. to Participate in the 2025 ICR Conference

Freshpet, Inc. to Report Fourth Quarter and Full Year 2024 Results and Participate in the CAGNY Conference on Thursday, February 20, 2025

Freshpet, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Freshpet, Inc. - FRPT

Mutual Funds

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Comments

Freshpet

뉴스

파트너 / 기고자

벤징가 글로벌